Sort   by:  
 Page size 
ProteomicsHypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Substances of Homologous Standardized Transplant Products in Tendon Regenerative Medicine
Human fetal progenitor tenocytes (hFPT) produced in defined cell bank systems have recently been characterized and qualified as potential therapeutic cell sources in tendon regenerative medicine. In view of further optimizing the manufacture of the cell-based active substance, the effects of hypoxic...
ORGANISM(S): Homo sapiens (Human) 
2022-02-15 | PXD028359 | Pride
Proteomics Cell manufacture Hypoxia Standardized transplants Tendon affections Human progenitor tenocytes Regenerative medicine 
UnknownIndustrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.
Not available
S-EPMC8066015 | biostudies-literature
UnknownComparison Between Ultrasonographic and Standing Magnetic Resonance Imaging Findings in the Podotrochlear Apparatus of Horses With Foot Pain.
Not available
S-EPMC8287171 | biostudies-literature
UnknownRandomized controlled trial demonstrates the benefit of RGTA® based matrix therapy to treat tendinopathies in racing horses.
Not available
S-EPMC5844532 | biostudies-literature
UnknownProcess Optimization and Efficacy Assessment of Standardized PRP for Tendinopathies in Sports Medicine: Retrospective Study of Clinical Files and GMP Manufacturing Records in a Swiss University Hospital.
Not available
S-EPMC10135571 | biostudies-literature
Sort   by:  
 Page size